本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioCryst製藥

8.12
-0.1700-2.05%
盤後8.120.00000.00%19:53 EDT
成交量:359.18萬
成交額:2,931.45萬
市值:20.75億
市盈率:-5.39
高:8.40
開:8.30
低:8.11
收:8.29
52周最高:11.22
52周最低:6.00
股本:2.56億
流通股本:2.22億
量比:0.66
換手率:1.62%
股息:- -
股息率:- -
每股收益(TTM):-1.5054
每股收益(LYR):1.21
淨資產收益率:587.33%
總資產收益率:52.86%
市淨率:-4.57
市盈率(LYR):6.71

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/04

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/06/29

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report